Back

Major bleeding risk in patients 75 years of age or older with non-valvular atrial fibrillation initiating oral anticoagulants: a real-world comparison of warfarin, apixaban, dabigatran, or rivaroxaban

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation II Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

22 More presentations in this session

Presentation thumbnail
Doctor E. Ridha (London, GB)
Abstract Slides
Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Presentation thumbnail
Doctor E. Nguyen (Storrs, US)
Abstract Slides
Presentation thumbnail
Doctor G. Laugaudin (Montpellier, FR)
Abstract
Presentation thumbnail
Professor J. Piccini (Durham, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Anticoagulation in atrial fibrillation II

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources